Kit expression in male germ cell tumors

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1685-1688

  Nikolaou, M ^a,h   Valavanis, C ^b   Aravantinos, G ^c   Fountzilas, G ^d   Tamvakis, N ^e   Lekka, I ^b   Arapantoni Dadioti, P ^b   Zizi, A ^f   Ghiconti, I ^g   Economopoulos, Th ^a   Pectasides, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c AGII ANARGIRI CANCER HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e SISMANOGLIO HOSPITAL   (Greece)

^f TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^g AGIA OLGA HOSPITAL   (Greece)

^h NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Germ cell tumors; Kit

Indexed keywords

PROTEIN KIT; RECEPTOR PROTEIN; STEM CELL FACTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TERATOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SEMINOMA; TROPHOBLASTIC TUMOR; UNDIFFERENTIATED CARCINOMA;

ADOLESCENT; ADULT; AGED; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROTO-ONCOGENE PROTEINS C-KIT; UP-REGULATION;

EID: 34249303467     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Bosl G, Sheinfeld J, Bajorin DF, Motzer RJ and Chaganti RSK: Cancer of the testis. In: De Vita VT, Hellman S and Rosenberg SA (eds.). Principles and Practice of Oncology (6th edition). Lippincott Williams and Wilkins, pp. 1491-1518, 2001.
2. Bokemeyer C, Kollmannsberger C, Hastrick A, Beyer J, Gerl A, Casper J, Metzner B, Hartmann JT, Schmoll HJ and Kanz L: Treatment of patients with cisplatin-refractory testicular germ cell cancer. Int J Cancer 83: 1181-1192, 1999.
3. Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M, Gaglia A, Kostopoulou V, Mylonakis N and Skarlos D: Gemcitabine and oxaliplatin in patients with cisplatin-refractory germ cell tumors: a phase II study. Ann Oncol 15: 493-497, 2004.
4. Heinreich MC, Blanke CD, Druker BJ and Corless CL: Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20: 1692-1703, 2002.
5. McIntyre A, Summersgill B, Grygalewicz B, Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R, Cooper C, Clark J, Oosterhuis JW, Looijenga LH and Shipley J: Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65: 8085-8089, 2005.
6. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A and Heinrich MC: KIT mutations are common in testicular seminomas. Am J Pathol 164: 305-313, 2004.
7. Nakai Y, Nonomura N, Oka D, Shiba M, Arai Y, Nakayama M, Inoue H, Nishimura K, Aozasa K, Mizutani Y, Miki T and Okuyama A: KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. Biochem Biophys Res Commun 337(1): 289-296, 2005.
8. Tian Q, Frierson J HF, Krystal GW and Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154: 1643-1647, 1999.